Global Allergy Immunotherapies Market to Show Further Growth, Expects Infiniti Research in Its New Report Available at MarketPublishers.com
11 Jul 2016 • by Natalie Aster
LONDON – At present, there is an upsurge of allergies given an increase in the environmental pollution. Besides, prevalence of allergic rhinitis and asthma is on the rise, while consumption of tobacco remains high.
Factors mentioned above and some other factors, such as existence of novel molecules in the pipeline and unmet medical needs that are high drive growth of the world’s market for allergy immunotherapies. This market is forecast to show a 7.3% CAGR over the period 2016-2020.
The marketplace faces such challenges as a high cost of an allergic immunotherapy and increased interest in CAM, among others.
Some key trends in this space comprise: SPIRE’s advent, SPLITT emergence, identification of new allergen targets, and more.
The global marketplace is dominated by such vendors as Merck Group, ALK-Abello and Stallergenes, to name a few.
New research report “Global Allergy Immunotherapies Market 2016-2020” drawn up by Infiniti Research offers an insightful analysis of the global allergy immunotherapies marketplace. This study starts with detailed coverage of allergies, with a special focus made on their prevalence.
It proceeds with a detailed pipeline analysis and segments the market on the basis of product types. The report also casts light on regional marketplaces as well as their performance.
The research study pinpoints drivers of the global market, challenges and trends and discusses impact they have on this space. The competitive scenario is explored in the report, too. Vendors’ profiles and future projections through 2020 are on hand in the study, too.
- bird’s eye view on the marketplace;
- details on drivers, challenges and trends;
- insights into the competitive landscape;
- future outlook;
- profiles of vendors;
- and more.
More new studies by Infiniti Research are available at its page.